NASDAQ:ADMS - Adamas Pharmaceuticals, Inc.
$6.01
 $0.01
+0.17%
11:50AM EDT
2019-07-22
Adamas Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to achieve relief without tolerability issues. It has developed a portfolio of chrono-synchronous therapies to address chronic neurologic disorders. Its first product candidate is ADS-5102, a chrono-synchronous amantadine therapy, for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). It has completed Phase II proof-of-concept study of ADS-5102 in these patients. Its Phase III clinical program included three placebo-controlled trials: EASED, EASE LID and EASE LID 3. Its second product candidate is ADS-4101, an extended-release version of single-agent compound for the treatment of epilepsy (partial onset seizures). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ADMS     avg for
industry  
  avg for
sector  
42 stocks weight:  19. 97   217. 37   399. 45  
42 stocks rank:  3. 18 K 1. 27 K 716. 99  
# analyst opinions:  8. 00   13. 21   13. 71  
mean recommendation:  2. 10   2. 10   2. 04  

quick ratio:  6. 64   5. 49   1. 88  
current ratio:  7. 03   5. 87   2. 36  

target price low:  8. 00   83. 44   114. 90  
target price avg:  8. 51   106. 20   137. 90  
target price high:  6. 10   132. 30   158. 97  
1-yr high:  27. 30   111. 86   142. 57  
last close:  6. 00   86. 79   125. 44  
50-day avg:  5. 41   86. 68   122. 63  
200-day avg:  8. 97   89. 22   121. 38  
1-yr low:  4. 29   69. 78   100. 51  
volume:  224. 62 K 2. 62 M 3. 43 M
50-day avg volume:  397. 01 K 3. 20 M 4. 16 M
200-day avg volume:  540. 29 K 2. 99 M 4. 75 M

1-day return:  -0. 50 % -1. 30 % -0. 99 %
this week return:  0. 00 % 0. 45 % -0. 20 %
12-wk return:  -6. 83 % 0. 94 % 4. 84 %
52-wk return:  -77. 91 % -1. 30 % 10. 55 %

enterprise value (EV):  105. 16 M 45. 10 B 122. 38 B
market cap:  165. 20 M 38. 96 B 108. 40 B
EBITDA:  -109. 20 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 96   5. 38   11. 93  
enterprise/revenue (EV/R):  2. 44   57. 92   10. 21  
total revenue:  43. 16 M 9. 91 B 39. 98 B
total debt:  130. 59 M 10. 90 B 17. 48 B
debt/equity:  204. 32   57. 18   120. 05  
net income (common):  -125. 69 M 2. 07 B 4. 05 B

shares outstanding:  27. 53 M 538. 09 M 1. 24 B
shares:  15. 61 M 548. 00 M 1. 22 B
shares short:  4. 56 M 10. 98 M 11. 87 M
shares short prior month:  5. 31 M 9. 32 M 12. 05 M
short ratio:  12. 51   5. 60   3. 34  
short % of float:  25. 81 % 6. 48 % 2. 64 %
total cash/share:  6. 92   10. 98   9. 19  
total cash:  190. 64 M 5. 93 B 6. 10 B
free cash flow:  -69. 36 M 2. 92 B 4. 55 B
operating cash flow:  -100. 34 M 3. 80 B 5. 78 B

book value:  2. 32   13. 35   27. 45  
price/book:  2. 58   4. 60   8. 78  
gross profits:  33. 41 M 7. 44 B 36. 13 B
operating margins:  -256. 38 % -308. 40 % -28. 55 %
EBITDA margins:  -253. 03 % 13. 17 % 23. 38 %
profit margins:  -291. 22 % 10. 44 % 14. 18 %
gross margins:  97. 63 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -4. 61   2. 10   4. 23  
forward EPS:  -2. 55   3. 45   7. 10  
P/E:  -1. 30   1. 90   32. 10  
forward P/E:  -2. 35   6. 46   15. 47  
PE/G:  -0. 00   0. 70   -0. 54  
growth:  356. 90 % 265. 63 % 79. 11 %
earnings high:  -0. 82   0. 89   1. 68  
earnings avg:  -0. 98   0. 70   1. 57  
earnings low:  -1. 10   0. 46   1. 46  
revenue high:  13. 60 M 2. 57 B 11. 07 B
revenue avg:  12. 88 M 2. 51 B 10. 91 B
revenue low:  12. 34 M 2. 45 B 10. 73 B
return on assets:  -26. 52 % -2. 34 % 5. 28 %
return on equity:  -107. 64 % -90. 08 % 133. 53 %
revenue growth:  356. 90 % 265. 25 % 73. 68 %
revenue/share:  1. 58   12. 72   60. 04  

beta (1yr vs S&P500):  1. 68   1. 27   0. 91  
sharpe (1yr):  -1. 77   0. 16   0. 77  

held % insiders:  2. 11 % 6. 06 % 3. 29 %
held % institutions:  114. 84 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : ADMS
.    104.908 =       104.908 :: --> INITIAL WEIGHT <--
.    - 4.607 =       100.301 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.987 =       199.287 :: P/E factor
.    x 2.209 =       440.218 :: PE/G factor
.    x 1.503 =       661.851 :: beta factor
.    x 0.753 =       498.158 :: sharpe factor
.    x 2.801 =       1395.57 :: current ratio factor
.    x 1.085 =      1514.205 :: quick ratio factor
.    x 1.039 =      1573.561 :: short ratio factor
.    x 3.016 =      4745.094 :: revenue growth factor
.    x 1.042 =       4944.73 :: EV/R factor
.    x 1.019 =      5036.489 :: price-to-book factor
.    x 0.757 =      3811.155 :: debt-to-revenue factor
.    x 1.604 =      6113.486 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     12965.439 :: sector+industry 1-year gains factor
.    x 1.009 =     13087.678 :: industry 12-weeks return factor
.    x 1.308 =     17117.224 :: industry 2-weeks return factor
.    x 1.453 =     24863.155 :: 5-day avg > 50-day avg
.    / 1.989 =     12499.062 :: overall "drift" factor
.    x 0.891 =     11131.366 :: largest single-day jump factor
.    x 0.089 =        995.65 :: low price factor
.    x 1.131 =      1126.371 :: notable returns + performance factor
.      x 3.3 =      3717.521 :: performance vs s&p500 factor
.                               --> PROJECTIONS <--
.    x 0.742 =      2759.609 :: forward EPS factor
.    x 0.906 =      2501.216 :: forward P/E factor
.    x 1.185 =      2963.222 :: industry recommendation factor
.    x 2.059 =      6102.233 :: company recommendation factor
.    x 1.003 =      6119.108 :: factor historical industry gain for week 29
.    x 9.781 =     59849.136 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        15.641 :: reduced for readability
.    + 4.332 =        19.973 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     19.973 :: FINAL WEIGHT for NASDAQ:ADMS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org